Analyst Ratings for Ligand Pharmaceuticals Inc. (LGND)

Updated: 2017-07-28

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was awarded an average rating of Buy from investment analysts following the stock. LGND had previously received a consensus rating of Buy a month ago.

4 analysts declared LGND a buy, 0 gave an overweight rating, 1 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Several price targets were given for LGND by the analysts covering the stock. The highest price target was 160, implying a possible profit of 31.95 percent. The most pessimistic analyst gave a price target of 103, implying potential capital losses of -15.06 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates upwards for this quarter, by about 5.46 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -21.71 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.73 percent. If we look at the last 90 days instead, we find a net average change of -5.94 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. Also over the last month, 1 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

In the trailing 52-weeks, LGND hit 139.79 at the highest peak, while it's lowest trading point was 87.50. The current market price is above the trailing year's low by 38.58 percent, and below the high by 13.26 percent. LGND has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The LGND value stock report compares LGND to some of its peers using value stock charts. The market cap of LGND is $2.54 billion. LGND is estimated to release their earnings results for the quarter on 0000-00-00, days from today.